Aurore Rampanou

1.5k total citations
17 papers, 859 citations indexed

About

Aurore Rampanou is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Aurore Rampanou has authored 17 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Aurore Rampanou's work include Cancer Genomics and Diagnostics (11 papers), Cancer Cells and Metastasis (7 papers) and Ocular Oncology and Treatments (5 papers). Aurore Rampanou is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Cancer Cells and Metastasis (7 papers) and Ocular Oncology and Treatments (5 papers). Aurore Rampanou collaborates with scholars based in France, Tunisia and Italy. Aurore Rampanou's co-authors include François‐Clément Bidard, Jean‐Yves Pierga, Olivier Lantz, Marc‐Henri Stern, Vincent Servois, Sophie Piperno‐Neumann, Charlotte Proudhon, Jordan Madic, Maud Milder and Francesca Riva and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Oncogene.

In The Last Decade

Aurore Rampanou

17 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurore Rampanou France 11 540 448 292 268 130 17 859
Lauren G. Aoude Australia 16 287 0.5× 434 1.0× 634 2.2× 86 0.3× 202 1.6× 29 1.0k
Kimberly M. Komatsubara United States 15 131 0.2× 370 0.8× 309 1.1× 198 0.7× 329 2.5× 25 810
Michelle R. Pereira Australia 13 510 0.9× 415 0.9× 322 1.1× 179 0.7× 59 0.5× 19 735
Gowtham Jayakumaran United States 11 246 0.5× 237 0.5× 562 1.9× 275 1.0× 18 0.1× 16 918
Timothy Taxter United States 15 283 0.5× 421 0.9× 440 1.5× 186 0.7× 28 0.2× 28 781
Virginie Caux‐Moncoutier France 11 234 0.4× 495 1.1× 653 2.2× 79 0.3× 99 0.8× 12 1.0k
Christina Manley United States 12 214 0.4× 183 0.4× 438 1.5× 143 0.5× 15 0.1× 13 633
Annette H. Parmiter United States 16 234 0.4× 272 0.6× 527 1.8× 143 0.5× 20 0.2× 17 859
Brigitte L. Thériault Canada 12 164 0.3× 299 0.7× 519 1.8× 29 0.1× 140 1.1× 18 757
Nancy J. Nesslinger Canada 10 97 0.2× 521 1.2× 305 1.0× 141 0.5× 57 0.4× 12 943

Countries citing papers authored by Aurore Rampanou

Since Specialization
Citations

This map shows the geographic impact of Aurore Rampanou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurore Rampanou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurore Rampanou more than expected).

Fields of papers citing papers by Aurore Rampanou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurore Rampanou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurore Rampanou. The network helps show where Aurore Rampanou may publish in the future.

Co-authorship network of co-authors of Aurore Rampanou

This figure shows the co-authorship network connecting the top 25 collaborators of Aurore Rampanou. A scholar is included among the top collaborators of Aurore Rampanou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurore Rampanou. Aurore Rampanou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rodrigues, Manuel, Toulsie Ramtohul, Aurore Rampanou, et al.. (2024). Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp. Nature Communications. 15(1). 8851–8851. 12 indexed citations
2.
Mariani, Pascale, François‐Clément Bidard, Aurore Rampanou, et al.. (2023). Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma. Annals of Surgery. 278(4). e827–e834. 10 indexed citations
3.
Stern, Marc‐Henri, Nicolas Kiavué, Luc Cabel, et al.. (2022). Microsatellite instability detection in breast cancer using drop-off droplet digital PCR. Oncogene. 41(49). 5289–5297. 12 indexed citations
4.
Champ, Jérôme, Aurore Rampanou, Jean‐Yves Pierga, et al.. (2022). Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach. Cancers. 14(8). 1890–1890. 5 indexed citations
5.
Cabel, Luc, Frédérique Berger, Paul Cottu, et al.. (2021). Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial. British Journal of Cancer. 124(7). 1207–1213. 47 indexed citations
6.
Jeannot, Emmanuelle, Lauren Darrigues, Marc Michel, et al.. (2020). A single droplet digital PCR for ESR1 activating mutations detection in plasma. Oncogene. 39(14). 2987–2995. 42 indexed citations
7.
Cabel, Luc, Francesca Riva, Vincent Servois, et al.. (2017). Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. Annals of Oncology. 28(8). 1996–2001. 224 indexed citations
8.
Riva, Francesca, François‐Clément Bidard, Alexandre Houy, et al.. (2017). Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Clinical Chemistry. 63(3). 691–699. 158 indexed citations
9.
Pierga, Jean‐Yves, Francesca Riva, Alexandre Houy, et al.. (2016). Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer. Annals of Oncology. 27. vi79–vi79. 7 indexed citations
10.
Eveno, Clarisse, Patricia Hainaud, Aurore Rampanou, et al.. (2014). Proof of prometastatic niche induction by hepatic stellate cells. Journal of Surgical Research. 194(2). 496–504. 40 indexed citations
11.
Piperno‐Neumann, Sophie, Jordan Madic, Pascale Mariani, et al.. (2013). Circulating tumor DNA (ctDNA) in metastatic uveal melanoma (MUM): Correlation with outcome in 87 patients (pts) from Institut Curie. Acta Ophthalmologica. 91(s252). 0–0. 1 indexed citations
12.
Bidard, François‐Clément, Jordan Madic, Pascale Mariani, et al.. (2013). Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. International Journal of Cancer. 134(5). 1207–1213. 146 indexed citations
13.
Madic, Jordan, Sophie Piperno‐Neumann, Vincent Servois, et al.. (2012). Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma. Clinical Cancer Research. 18(14). 3934–3941. 65 indexed citations
14.
Eveno, Clarisse, Carole Le Hénaff, Philippe Soyer, et al.. (2012). Tumor and Non-Tumor Liver Angiogenesis Is Traced and Evaluated by Hepatic Arterial Ultrasound in Murine Models. Ultrasound in Medicine & Biology. 38(7). 1195–1204. 9 indexed citations
15.
Eveno, Clarisse, Dong Broquères-You, Jean-Guillaume Féron, et al.. (2011). Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis. American Journal Of Pathology. 178(4). 1861–1869. 55 indexed citations
16.
Ramírez, Vanessa, Aurore Rampanou, Wei Zhang, et al.. (2009). Phosphatidylinositol 3-Kinase/Akt Pathway Targets Acetylation of Smad3 through Smad3/CREB-binding Protein Interaction. Journal of Biological Chemistry. 284(36). 23912–23924. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026